Differential effects of CCK-JMV-180 on food intake in rats and mice (original) (raw)

CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors

Celia Sharp

Biochimica Et Biophysica Acta-molecular Cell Research, 1989

View PDFchevron_right

A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey

K. Asin

Pharmacology Biochemistry and Behavior, 1992

View PDFchevron_right

Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCKAreceptor blockade

Carmelo Scarpignato

British Journal of Pharmacology, 1998

View PDFchevron_right

Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat

Carmelo Scarpignato

Journal of Physiology-Paris, 1997

View PDFchevron_right

Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans

Juergen Drewe

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2000

View PDFchevron_right

Stimulation of the exocrine pancreas via a third CCK-receptor subtype?

stefan pierzynowski

Livestock Science, 2007

View PDFchevron_right

Pharmacological and biochemical evidence for the simultaneous expression of CCK B /gastrin and CCK A receptors in the pig pancreas

Evelyne F Lhoste

British Journal of Pharmacology, 1997

View PDFchevron_right

Novel CCK Analogs for Studying CCK-B Receptor

Mutsuaki Suzuki

Annals of The New York Academy of Sciences, 1994

View PDFchevron_right

Differential bile-pancreatic secretory effects of CCK-58 and CCK-8

Vincent Wu

AJP: Gastrointestinal and Liver Physiology, 2004

View PDFchevron_right

Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells

Maria Björkqvist

British Journal of Pharmacology, 1999

View PDFchevron_right

Pharmacological evaluation of IQM-95,333, a highly selective CCK A receptor antagonist with anxiolytic-like activity in animal models

Isabel Gomez-monterrey

British Journal of Pharmacology, 1997

View PDFchevron_right

Correlation between phospholipid breakdown, intracellular calcium mobulization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues

Marie-christine Galas

Cellular Signalling, 1990

View PDFchevron_right

CCK-58 elicits both satiety and satiation in rats while CCK-8 elicits only satiation

David Cummings

Peptides, 2014

View PDFchevron_right

Presence and localization of CCK receptor subtypes in calf pancreas

Jean-Pierre Laine

Regulatory Peptides, 2003

View PDFchevron_right

Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo

K. Asin

Journal of medicinal chemistry, 1992

View PDFchevron_right

Molecular properties of solubilized CCK receptor from guinea-pig pancreas

Ahmed Zahidi

Regulatory Peptides, 1986

View PDFchevron_right

Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue

Helmut Friess

Gastroenterology, 2003

View PDFchevron_right

The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas

Bodil Ohlsson

International journal of pancreatology : official journal of the International Association of Pancreatology, 1998

View PDFchevron_right

Increased CCK-Response to Proteinase Inhibitor Feeding After Induction of Pancreatic Hypertrophy in Rats

Burkhard Göke

Pancreas, 1988

View PDFchevron_right

CCK antagonists: Pharmacology and therapeutic interest

Jean-louis Junien, Joseph Wettstein

Pharmacology & Therapeutics, 1994

View PDFchevron_right

Long-Term Blockade of Cholecystokinin (CCK): Effects of L 364,718 (a CCK Receptor Antagonist) on Pancreatic Enzyme Storage and Secretion

Andres Monteros

Pancreas, 1997

View PDFchevron_right

The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight

Robin Kanarek

Journal of Clinical Investigation, 1999

View PDFchevron_right

Abdominal vagal mediation of the satiety effects of CCK in rats

Bernd Fritzsch

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004

View PDFchevron_right

Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa

Akos Heinemann, Gábor Pethô

British Journal of Pharmacology, 1995

View PDFchevron_right

Effect of some novel synthetic analogues of CCK4 on insulin and glucagon secretion

Faiyaz Ahmad

Acta Diabetologica, 1989

View PDFchevron_right

Effects of a new cholecystokinin analogue (JMV 236) on food intake and brain monoamines in the rat

Mariela Orosco

Neuropeptides, 1990

View PDFchevron_right

Monitor peptide gene expression is increased by exogenous CCK in the rat pancreas and in a rat pancreatic acinar cell line (AR4-2J)

Tohru Fushiki

FEBS Letters, 1992

View PDFchevron_right

Effects of Six Cholecystokinin (CCK) Fragments on Insulin Secretion in the Mouse

Ingmar Lundquist

Acta Pharmacologica et Toxicologica, 1986

View PDFchevron_right

Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat

Carmelo Scarpignato

British Journal of Pharmacology, 1989

View PDFchevron_right

Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats

T Solomon

Peptides, 1991

View PDFchevron_right

Behavioral effects of AR-R 15849, a highly selective CCK-A agonist

Tom Hudzik

Pharmacology, biochemistry, and behavior, 1999

View PDFchevron_right

Characterization of novel peptoid agonists for the CCK-A receptor

Emil Toescu

Regulatory Peptides, 1996

View PDFchevron_right

CCK inhibits the orexigenic effect of peripheral ghrelin

Viola Andresen, Yvette Tache

AJP: Regulatory, Integrative and Comparative Physiology, 2004

View PDFchevron_right

Discovery of Pyrimidine Carboxamides as Potent and Selective CCK1 Receptor Agonists

Douglas MacNeil

2011

View PDFchevron_right

2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity

Alison Strack

Bioorganic & Medicinal Chemistry Letters, 2008

View PDFchevron_right